NDC 70518-4479-01 - Metformin HCl
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4479
- Requested NDC
- 70518-4479-01
- Package NDCs from labels
- 70518-4479-0, 70518-4479-1, 70518-4479-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin Hydrochloride Tablets USP | REMEDYREPACK INC. | 2026-09-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4479-0 | Metformin HCl | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 1 | |
| 70518-4479-1 | Metformin HCl | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin hydrochloride ER | METFORMIN HYDROCHLORIDE | AvKARE | 1aa40000-877f-8ea4-e063-6394a90a0e31 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Linagliptin and metformin hydrochloride | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Novadoz Pharmaceuticals LLC | 5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Mullan Pharmaceutical Inc. | 082b4de9-e452-fe71-e063-6394a90ac863 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | 861007 861010 861004 786Z46389E |
| Walgreens Ultra Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4533-2061-e063-6394a90a6e73 | 2025-10-17 | Warnings | B697894SGQ |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | AvKARE | 13be49d2-0ce9-a78a-e557-ded85ddc808f | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 403349a1-ec19-8982-e063-6294a90aa060 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | ANDA090564 861007 786Z46389E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 4be72741-4f6d-6689-e054-00144ff8d46c | 2025-09-22 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Coupler LLC | 3eeee3b7-188a-05a0-e063-6294a90a1853 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| Metformin | METFORMIN | Coupler LLC | 3edc9b51-ddee-61f8-e063-6294a90ad3c5 | 2025-09-15 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Dry eye relief | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | f8da3af5-9172-4023-be82-0fd5bd891616 | 2025-09-12 | Warnings | B697894SGQ |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Ascend Laboratories, LLC | 8c7835fa-3f68-4850-b1da-34893bafb485 | 2025-08-28 | Boxed warning, Warnings, Adverse reactions | 861007 861010 861004 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3d450933-8d9d-27de-e063-6294a90ae6d9 | 2025-08-26 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3cbb802d-d493-255e-e063-6294a90a32f2 | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 53ba7031-be87-47a5-ade7-494c6c489cc6 | 2025-08-18 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | e1ebb146-acfd-4301-a79c-f5bb243f8575 | 2025-08-06 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | e55ee270-5eb9-4848-8529-9af2a79669c0 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | B697894SGQ |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | B697894SGQ |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | B697894SGQ |
| Metformin HCL | METFORMIN HCL | Direct_Rx | 2ffeb25a-76a9-01e6-e063-6394a90ae332 | 2025-07-25 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.